Applications of biosensors in Alzheimer's disease diagnosis

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a progressive and irreversible cognitive decline. Currently, it affects 36 million people and due to population ageing it is estimated that in 2030 disease incidence will reach 60 million individuals. The precise diagnosi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Talanta (Oxford) 2020-04, Vol.210, p.120644-120644, Article 120644
Hauptverfasser: Brazaca, Laís Canniatti, Sampaio, Isabella, Zucolotto, Valtencir, Janegitz, Bruno Campos
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a progressive and irreversible cognitive decline. Currently, it affects 36 million people and due to population ageing it is estimated that in 2030 disease incidence will reach 60 million individuals. The precise diagnosis of AD is still a complex task, being mainly performed by cerebrospinal fluid (CSF) analysis or neuroimaging techniques such as positron emission tomography (PET) and magnetic resonance imaging (MRI). Despite being effective these techniques are expensive, time-consuming and not accessible for most part of the population. In this scenario biosensors are presented as promising alternatives for simple, rapid and low cost diagnosis of AD. In this revision we summarize the recent advances on biosensors that brings more accessibility to AD diagnosis. We introduce the most used biorecognition elements in miniaturized biosensing systems as well as AD biomarkers present in CSF, in plasma and in genetic material which can be used for disease identification even in early stages. The recent developed biosensors for AD diagnosis using optical, electrochemical and colorimetric techniques as well as their strategies and analytical performances are discussed. Advancements in signal amplification methodologies with nanomaterials to increase biosensors sensitivity are also presented. This review highlights the potential of biosensors to be used as an accurate and portable tool to improve the early AD diagnosis. [Display omitted] •Alzheimer’s disease (AD) is the most common degenerative disorder in the world.•We present the state-of-the-art of biosensors for AD diagnosis.•Devices applying diverse biorecognition elements and various categoties of AD biomarkers are presented.•Recent Advancements in signal amplification and the future of biosensors in AD point-of-care diagnosis are discussed.•From the best of our knowledge, this review offers the broadest panorama of the state-of-the-art in biosensors for AD.
ISSN:0039-9140
1873-3573
DOI:10.1016/j.talanta.2019.120644